Provision of Lateral Flow testing devices for the detection of COVID-19 viral antigens
What the buyer wrote
The Omicron outbreak and its high transmissibility has however led to an urgent and unforeseeable surge in demand for LFTs. Due to this urgency, UKHSA is unable to comply with the time periods required for a further competitive tender (whether under the DPS or otherwise), as any delay will risk the current stock of competitively-procured LFTs being exhausted thereby introducing a significant risk to public health. <br/>UKHSA has therefore used the negotiated procedure without prior publication under Regulation 32(2)(c) of the Public Contracts Regulations 2015 to award a contract to Tanner Pharma UK LImited on 29 December 2021 for £169,000,000.
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- Provision of Lateral Flow testing devices for the detection of COVID-19 viral antigens
- How they are buying
- Given to one supplier, no competitionNobody else was asked, and the buyer has to be able to justify that.
- Type
- goods
- Kind of work
- Health and social care
Who the buyer named
Commercial Operations was the named contact on this notice.